M&A Deal Summary

Fagron Acquires Amber Compounding Pharmacy

On December 19, 2025, Fagron acquired life science company Amber Compounding Pharmacy

Acquisition Highlights
  • This is Fagron’s 4th transaction in the Life Science sector.
  • This is Fagron’s 1st transaction in Singapore.

M&A Deal Summary

Date 2025-12-19
Target Amber Compounding Pharmacy
Sector Life Science
Buyer(s) Fagron
Deal Type Add-on Acquisition

Target

Amber Compounding Pharmacy

Singapore, Singapore
Amber Compounding Pharmacy is a specialty pharmacy that provides dispensing and clinical support services for patients with complex, long-term, and rare conditions. Amber Compounding Pharmacy is based in Singapore, Singapore.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Fagron

Nazareth, Belgium

Category Company
Founded 1990
Sector Medical Products
Employees3,282
Revenue 872M EUR (2024)
DESCRIPTION

Fagron is a provider of pharmaceutical raw materials, compounded products, repacked goods, packaging materials and pharmacy equipment. Fagron was founded in 1990 and is based in Nazareth, Belgium.


DEAL STATS #
Overall 19 of 19
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 17 of 17
Country: Singapore M&A 1 of 1
Year: 2025 M&A 8 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-12-19 Vepakum

Sao Paulo, Brazil

Vepakum is a manufacturer of plastic packaging products serving the cosmetic and pharmaceutical sectors. Vepakum was founded in 2005 and is headquartered in Sao Paulo, Brazil.

Buy -